Ustekinumab Injection Market Revenue 2024 to 2034
Ustekinumab Injection Market Revenue 2024 to 2034
the Ustekinumab Injection Market forecast 2024–2034, rising from USD 11.49 Bn to USD 33.23 Bn at an 11.20% CAGR with increasing adoption.
Report ID: 10314
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 11.49 Bn
Forecast Year,
USD 33.23 Bn
CAGR, 2025 -
11.20%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Ustekinumab Injection Market Size Analysis
Ustekinumab Injection Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Plaque Psoriasis | 3.22 | 3.57 | 3.96 | 4.39 | 4.87 | 5.44 | 6.07 | 6.74 | 7.48 | 8.26 | 9.20 |
| Psoriatic Arthritis | 2.30 | 2.56 | 2.85 | 3.19 | 3.56 | 3.95 | 4.39 | 4.89 | 5.41 | 6.03 | 6.74 |
| Crohn’s Disease | 3.45 | 3.82 | 4.26 | 4.72 | 5.24 | 5.79 | 6.43 | 7.13 | 7.93 | 8.83 | 9.75 |
| Ulcerative Colitis | 2.07 | 2.32 | 2.57 | 2.87 | 3.20 | 3.57 | 3.97 | 4.42 | 4.97 | 5.56 | 6.19 |
| Other | 0.46 | 0.51 | 0.57 | 0.64 | 0.71 | 0.79 | 0.88 | 0.99 | 1.09 | 1.21 | 1.35 |
Ustekinumab Injection Market Size By Dosage Form 2024 to 2034 (USD )
| Dosage Form | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Prefilled Syringe | 7.36 | 8.16 | 9.07 | 10.07 | 11.20 | 12.50 | 13.87 | 15.46 | 17.17 | 19.10 | 21.22 |
| Vial | 4.14 | 4.62 | 5.14 | 5.73 | 6.38 | 7.04 | 7.87 | 8.70 | 9.71 | 10.78 | 12.01 |
Ustekinumab Injection Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 5.52 | 6.15 | 6.85 | 7.60 | 8.50 | 9.50 | 10.55 | 11.71 | 13.08 | 14.52 | 16.17 |
| Specialty Pharmacies | 3.91 | 4.34 | 4.82 | 5.36 | 5.91 | 6.54 | 7.31 | 8.17 | 9.03 | 10.07 | 11.17 |
| Retail/Online | 2.07 | 2.30 | 2.55 | 2.84 | 3.17 | 3.50 | 3.87 | 4.29 | 4.76 | 5.30 | 5.90 |
Ustekinumab Injection Market Size By Payer Type 2024 to 2034 (USD )
| Payer Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Public/Govt | 4.83 | 5.39 | 5.98 | 6.65 | 7.41 | 8.18 | 9.09 | 10.07 | 11.28 | 12.55 | 14.01 |
| Private | 5.98 | 6.63 | 7.38 | 8.20 | 9.11 | 10.18 | 11.33 | 12.64 | 13.95 | 15.51 | 17.19 |
| Self-pay/Other | 0.69 | 0.76 | 0.85 | 0.95 | 1.05 | 1.18 | 1.32 | 1.46 | 1.64 | 1.82 | 2.03 |
Ustekinumab Injection Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 5.29 | 5.86 | 6.54 | 7.26 | 8.08 | 8.97 | 9.95 | 11.02 | 12.26 | 13.66 | 15.14 |
| Europe | 3.45 | 3.86 | 4.26 | 4.73 | 5.27 | 5.85 | 6.52 | 7.28 | 8.09 | 8.99 | 10.06 |
| Asia Pacific | 2.07 | 2.29 | 2.56 | 2.86 | 3.17 | 3.56 | 3.96 | 4.43 | 4.90 | 5.43 | 6.04 |
| Latin America | 0.34 | 0.38 | 0.43 | 0.48 | 0.53 | 0.59 | 0.65 | 0.72 | 0.80 | 0.89 | 0.99 |
| Middle East & Africa | 0.34 | 0.38 | 0.43 | 0.47 | 0.52 | 0.58 | 0.65 | 0.72 | 0.81 | 0.91 | 1.01 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
